# Study of the Effects of Dopaminergic Medications on Dopamine Transporter Density in Subjects With Parkinson's Disease

> **NCT00129181** · NA · COMPLETED · sponsor: **Institute for Neurodegenerative Disorders** · enrollment: 30 (actual)

## Conditions studied

- Parkinson Disease
- Parkinsonian Syndrome

## Interventions

- **DRUG:** cabergoline
- **DRUG:** carbidopa/levodopa
- **PROCEDURE:** DATscan and SPECT imaging

## Key facts

- **NCT ID:** NCT00129181
- **Lead sponsor:** Institute for Neurodegenerative Disorders
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-01
- **Primary completion:** 2006-12
- **Final completion:** 2007-01
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2009-08-28

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00129181

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00129181, "Study of the Effects of Dopaminergic Medications on Dopamine Transporter Density in Subjects With Parkinson's Disease". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00129181. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*